"10.1371_journal.pone.0055948","plos one","2013-02-04T00:00:00Z","Kathryn M Munro; Kirsty J Dixon; Melissa M Gresle; Anna Jonas; Dennis Kemper; William Doherty; Louis J Fabri; Catherine M Owczarek; Martin Pearse; Andrew W Boyd; Trevor J Kilpatrick; Helmut Butzkueven; Ann M Turnley","Centre for Neuroscience Research, The University of Melbourne, Victoria, Australia; Department of Anatomy and Neuroscience, The University of Melbourne, Victoria, Australia; Department of Medicine, Melbourne Brain Centre at the Royal Melbourne Hospital, The University of Melbourne, Victoria, Australia; MS Division, Florey Neuroscience Institutes, Melbourne, Victoria, Australia; CSL Ltd, Parkville, Victoria, Australia; Queensland Institute of Medical Research, Brisbane, Queensland","Conceived and designed the experiments: AMT HB AWB TJK. Performed the experiments: KMM KJD MG AJ DK WD. Analyzed the data: KMM KJD MG AJ AMT HB. Contributed reagents/materials/analysis tools: LF CO MP TJK. Wrote the paper: AMT HB KMM KJD MG.","The authors have read the journals policy and have the following conflicts: Martin Pearse, Louis Fabri, and Cathy Owczarek are employees of CSL Limited and who, for the studies described in this manuscript, coordinated the production and quality control of gram quantities of the EphA4-Fc blocker. Ann Turnley and Helmut Butzkueven have submitted a patent application regarding the use of EphA4 blockers in neuroinflammation, which was sponsored by CSL Ltd (WO 2010/141974). This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","02","Kathryn M Munro","KMM",13,TRUE,4,6,6,5,TRUE,TRUE,FALSE,0,NA,FALSE
